351 related articles for article (PubMed ID: 11846635)
1. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).
Roberts SM; Jordan KE; Warren DA; Britt JK; James RC
Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635
[TBL] [Abstract][Full Text] [Related]
2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
3. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
McClellan RO
Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
[TBL] [Abstract][Full Text] [Related]
4. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency.
Wang NC; Venkatapathy R; Bruce RM; Moudgal C
Regul Toxicol Pharmacol; 2011 Mar; 59(2):215-26. PubMed ID: 20951756
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenesis Bioassay of Vinylidene Chloride (CAS No. 75-35-4) in F344 Rats and B6C3F1 Mice (Gavage Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1982 May; 228():1-184. PubMed ID: 12778208
[TBL] [Abstract][Full Text] [Related]
7. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
8. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
Sanner T; Dybing E; Willems MI; Kroese ED
Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
[TBL] [Abstract][Full Text] [Related]
9. Comparison of carcinogen hazard characterisation based on animal studies and epidemiology.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):66-70. PubMed ID: 15667598
[TBL] [Abstract][Full Text] [Related]
10. A proposed methodology for selecting a trichloroethylene inhalation unit risk value for use in risk assessment.
Lewandowski TA; Rhomberg LR
Regul Toxicol Pharmacol; 2005 Feb; 41(1):39-54. PubMed ID: 15649826
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
12. Hazard identification and dose response of inhaled nickel-soluble salts.
Haber LT; Erdreicht L; Diamond GL; Maier AM; Ratney R; Zhao Q; Dourson ML
Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):210-30. PubMed ID: 10854127
[TBL] [Abstract][Full Text] [Related]
13. The weight of the evidence among group C carcinogens.
Engler R; Rinde E; Frick C; Quest J
Qual Assur; 1991 Oct; 1(1):51-69. PubMed ID: 1669970
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
16. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
17. Animal carcinogenicity studies: implications for the REACH system.
Knight A; Bailey J; Balcombe J
Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
[TBL] [Abstract][Full Text] [Related]
18. Follow-up study on the carcinogenicity of vinyl chloride and vinylidene chloride in rats and mice: tumor incidence and mortality subsequent to exposure.
Hong CB; Winston JM; Thornburg LP; Lee CC; WSoods JS
J Toxicol Environ Health; 1981 Jun; 7(6):909-24. PubMed ID: 7265317
[TBL] [Abstract][Full Text] [Related]
19. Development of an oral cancer slope factor for Aroclor 1268.
Warren DA; Kerger BD; Britt JK; James RC
Regul Toxicol Pharmacol; 2004 Aug; 40(1):42-53. PubMed ID: 15265605
[TBL] [Abstract][Full Text] [Related]
20. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
